This article is available to subscribers. Subscribe now. Already have an account? Sign in

Book ReviewFree Preview

Cystic Fibrosis

Cystic fibrosis is one of the most common inherited diseases in populations of European descent. The median life expectancy of patients with cystic fibrosis is on the rise and has changed dramatically, within a period of three decades, from approximately 10 years to approximately 38 years. This favorable result has been achieved through research; through the development of adequate medications, especially enteric-coated pancreatic enzymes; through the use of prophylactic medications; through treatment by multidisciplinary cystic fibrosis teams; and through early intervention for patients who have pulmonary exacerbations. The total number of patients with cystic fibrosis worldwide is not known, but . . .

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Jorrit Gerritsen, M.D., Ph.D.
University of Groningen, 9700 RB Groningen, the Netherlands

Print Subscriber? Activate your online access.